✦ LIBER ✦
Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype--ACOSOG Z1031
✍ Scribed by Ellis, M. J.; Suman, V. J.; Hoog, J.; Lin, L.; Snider, J.; Prat, A.; Parker, J. S.; Luo, J.; DeSchryver, K.; Allred, D. C.
- Book ID
- 111922181
- Publisher
- American Society of Clinical Oncology
- Year
- 2011
- Tongue
- English
- Weight
- 149 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.